Greenwich LifeSciences
GLSI
31 hedge funds and large institutions have $12.9M invested in Greenwich LifeSciences in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
128% more capital invested
Capital invested by funds: $5.64M → $12.9M (+$7.21M)
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
15% more funds holding
Funds holding: 27 → 31 (+4)
0.85% more ownership
Funds ownership: 4.17% → 5.02% (+0.85%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$645K |
| 2 |
Goldman Sachs
New York
|
+$512K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$442K |
| 4 |
HF
HRT Financial
New York
|
+$187K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$141K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$564K |
| 2 |
6CM
683 Capital Management
New York
|
-$206K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$17.7K |
| 4 |
Citigroup
New York
|
-$15.6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$11.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GWM
26
Geneos Wealth Management
Englewood,
Colorado
| $1.75K | – | – | – |
|
|
NSIM
27
North Star Investment Management
Chicago,
Illinois
| $1.02K | – | – | – |
|
28
Wells Fargo
San Francisco,
California
| $818 | – | – | – |
|
29
Macquarie Group
Sydney, NSW 2000,
Australia
| $2 | +$1.36K | +110 | New |
|
|
30
Ameriprise
Minneapolis,
Minnesota
| – | -$564K | -53,647 | Closed |
|
|
6CM
31
683 Capital Management
New York
| – | -$206K | -19,604 | Closed |
|
|
AF
32
Advisornet Financial
Minnetonka,
Minnesota
| – | -$526 | -50 | Closed |
|
33
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$123 | -10 | -42% |
|
|
CAL
34
Capital Advisors Ltd
Shaker Heights,
Ohio
| – | +$37 | +3 | New |
|
GLSI Hedge Fund Activity: Q1 2024 in Review
31 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q1 2024, worth a combined $12.9M — up 128% from $5.64M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new GLSI positions and 3 closed out — a net gain of 4 holders — while 10 added to existing stakes and 5 trimmed.
The largest buyer was Millennium Management, adding an estimated $645K. The largest seller was Ameriprise, exiting entirely with an estimated $564K sold.
- 31 institutional investors held Greenwich LifeSciences (GLSI) as of Q1 2024, up from 27 in Q4 2023.
- Funds reported $12.9M of Greenwich LifeSciences stock for Q1 2024, up 128% quarter-over-quarter.
- 7 funds opened new Greenwich LifeSciences positions in Q1 2024 and 3 closed out, a net change of +4 holders.
- The largest Greenwich LifeSciences buyer in Q1 2024 was Millennium Management, an estimated $645K added.
- The largest Greenwich LifeSciences seller in Q1 2024 was Ameriprise, an estimated $564K sold.
Based on aggregated 13F filings for Q1 2024.